Outpatient (ex Primary Care) market news & reports

Pressure grows to restrict investment in German health care

Pressure is growing for a change in German law restricting who can invest in healthcare. If enacted, it could effectively see some outpatient operators “banned”, and restrict who can do telehealth. Is such a development likely? HBI speaks to a trio of German healthcare experts to find out more.

December 16, 2022

Chris Toth, CEO, Varian, a Siemens Healthineers Company

In April last year, medical device giant Siemens Healthineers acquired Varian Medical Systems in one of the largest all cash MedTech transactions in history. HBI catches up with Varian CEO Chris Toth to find out more about the deal, and Varian’s plans for the future.

December 9, 2022

Scanmed buys Ars Medical

Polish multi-specialty healthcare company Scanmed has bought Polish oncology firm Ars Medical.

November 25, 2022

Affidea expands Spanish offering with further acquisition in Madrid

European imaging and cancer treatment provider Affidea has acquired outpatient specialist Clínica Algete in Madrid.

November 18, 2022

Inflation hits margins for Medicover and Terveystalo

Poor results have seen big share price drops at two of the sexier listed health care service groups. Medicover, the pan-emerging markets outpatient operator, saw shares fall 11% on Q3 figures showing a net loss of €18.4m and Terveystalo, the Finnish and Swedish outpatient group, fell 23% to €6.23 after revealing a net loss of €19.6m. Since the start of the year both have seen their share prices halve or worse. Inflation, labour shortages, Ukraine and a big shift in how health care is delivered post-Covid are behind the poor results.

November 4, 2022

Meloni’s promise to boost Italian healthcare could benefit for-profits

Italy's new right-wing alliance under Giorgia Meloni promises direct and indirect benefits for Italy’s private healthcare businesses.

September 29, 2022

Hungary’s private provider revenues surge – yet losses mount for many

The fast growing for-profit healthcare market in Hungary is scaling new peaks. HBI hears it could be worth as much as HUF 450-500bn (in excess of €1bn), and talks to a local operator to find out more about why revenue growth is not always translating into profit.

September 22, 2022

Recchi replaced at Affidea

Giuseppe Recchi is stepping down as CEO of Affidea, Europe’s largest imaging company. The new CEO will continue the company’s ambition to expand into more European markets.

September 2, 2022

Portuguese hospital groups face €191 million fine

The Autorldade da Concorrencia (AdC), the Portuguese Competition Authority, has sanctioned and imposed fines of €191 million on several private hospital groups and the Portuguese Private Hospitals Association (APHP).

July 18, 2022

HBI 2022: Affidea on increasing performance while improving patient experience

A breakfast briefing session at HBI 2022 by Affidea, the largest pan-European provider of advanced diagnostics, outpatient and cancer care, took a deep dive into driving operational efficiencies and improving patient experience.

Outpatient (ex Primary Care)

December 16, 2022

December 9, 2022

November 25, 2022

November 18, 2022

November 4, 2022

September 29, 2022

September 22, 2022

September 2, 2022

July 18, 2022

July 1, 2022

Our Services

Company

Resources

Our Services

Company

Resources

Find Us

Please wait while your search results are being generated.

Get a CLEAR picture on private healthcare services across Europe

Subscribe now to Healthcare Europa and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture on private healthcare services across Emerging Markets

Subscribe now to Healthcare Nova and get instant access to:

check

check

check

check

check

check

check

check

Know the pulse of the market from just £1040.

Get a CLEAR picture of ALL the top players in 22 sectors across 34 countries

Subscribe now to the only database of the Top 1,700 operators in Europe. Use it to:

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Get a CLEAR picture of the Top 1,300 players in Emerging Markets

Subscribe now to the only database of the Top 1,300 private healthcare operators in Emerging Markets . Use it to:

check

check

check

check

check

check

Instant access plus ongoing updatesfrom £1,895.

Know the pulse of the market
from just £1040.

Know the pulse of the market
from just £1040.

Subscribe now to the only database of the
Top 1,700 operators in Europe. Use it to:

Instant access plus ongoing updates
from £1,895.

Subscribe now to the only database of the Top 1,300 private
healthcare operators in Emerging Markets . Use it to:

Instant access plus ongoing updates
from £1,895.